BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6977542)

  • 1. Immunoreactive protein in adenosine deaminase deficient human lymphoblast cell lines.
    Wiginton DA; Hutton JJ
    J Biol Chem; 1982 Mar; 257(6):3211-7. PubMed ID: 6977542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic expression in partial adenosine deaminase deficiency. mRNA levels and protein turnover for the enzyme variants in human B-lymphoblast cell lines.
    Daddona PE; Davidson BL; Perignon JL; Kelley WN
    J Biol Chem; 1985 Mar; 260(6):3875-80. PubMed ID: 3871777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine deaminase messenger RNAs in lymphoblast cell lines derived from leukemic patients and patients with hereditary adenosine deaminase deficiency.
    Adrian GS; Hutton JJ
    J Clin Invest; 1983 Jun; 71(6):1649-60. PubMed ID: 6134754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts.
    Daddona PE; Kelley WN
    Biochim Biophys Acta; 1981 Apr; 658(2):280-90. PubMed ID: 6972784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
    Uberti J; Peterson WD; Lightbody JJ; Johnson RM
    J Immunol; 1983 Jun; 130(6):2866-70. PubMed ID: 6854019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation.
    Daddona PE; Mitchell BS; Meuwissen HJ; Davidson BL; Wilson JM; Koller CA
    J Clin Invest; 1983 Aug; 72(2):483-92. PubMed ID: 6603477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human adenosine deaminase and its binding protein in normal and adenosine deaminase-deficient fibroblast cell strains.
    Daddona PE; Frohman MA; Kelley WN
    J Biol Chem; 1980 Jun; 255(12):5681-7. PubMed ID: 7380831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme.
    Hirschhorn R; Beratis N; Rosen FS
    Proc Natl Acad Sci U S A; 1976 Jan; 73(1):213-7. PubMed ID: 1061119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of adenosine deaminase levels in human lymphoblasts.
    Daddona PE; Kelley WN
    Adv Enzyme Regul; 1982; 20():153-63. PubMed ID: 6981287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of an adenosine deaminase-deficient human histiocytic lymphoma cell line (DHL-9) and selection of mutants deficient in adenosir kinase and deoxycytidine kinase.
    Kubota M; Kamatani N; Daddona PE; Carson DA
    Cancer Res; 1983 Jun; 43(6):2606-10. PubMed ID: 6303563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
    Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive adenosine deaminase (ADA) in cultured fibroblasts from patients with combined immunodeficiency disease.
    Carson DA; Goldblum R; Keightley R; Seegmiller JE
    Adv Exp Med Biol; 1977; 76A():463-70. PubMed ID: 855722
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolation of mutant adenosine deaminase by coformycin affinity chromatography.
    Danton MJ; Coleman MS
    Anal Biochem; 1986 Nov; 159(1):233-9. PubMed ID: 3492941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning of cDNA sequences of human adenosine deaminase.
    Wiginton DA; Adrian GS; Friedman RL; Suttle DP; Hutton JJ
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7481-5. PubMed ID: 6200875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunochemical quantitation of human adenosine deaminase.
    Daddona PE; Frohman MA; Kelley WN
    J Clin Invest; 1979 Sep; 64(3):798-803. PubMed ID: 468994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A lymphoblastoid cell line from an adenosine deaminase deficient patient established by Epstein-Barr virus.
    Tsuchiya S; Narisawa K; Konno T; Tada K
    Tohoku J Exp Med; 1979 Oct; 129(2):105-10. PubMed ID: 227140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal and mutant human adenosine deaminase genes.
    Akeson AL; Wiginton DA; Hutton JJ
    J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential inhibition of adenosine deaminase deficient peripheral blood lymphocytes and lymphoid line cells by deoxyadenosine and adenosine.
    Hirschhorn R; Bajaj S; Borkowsky W; Kowalski A; Hong R; Rubinstein A; Papageorgiou P
    Cell Immunol; 1979 Feb; 42(2):418-23. PubMed ID: 311698
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative characterization of B-lymphoblastoid cell lines in adenosine deaminase deficiency and its heterozygote.
    Sawami H; Toyokawa Y; Ito K; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):721-9. PubMed ID: 2618547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxynucleoside overproduction in deoxyadenosine-resistant, adenosine deaminase-deficient human histiocytic lymphoma cells.
    Kubota M; Carrera CJ; Wasson DB; Carson DA
    Biochim Biophys Acta; 1984 May; 804(1):37-43. PubMed ID: 6372866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.